FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pazit Bar-On

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Living Beings

Physiology

Signal Transduction

Procedures

Nuclease Protection Assays

Co-author Network

Publications

TOP 3
Pazit Bar-On; Leslie Crews; Andrew O Koob; Hideya Mizuno; Anthony Adame; Brian Spencer; Eliezer Masliah
Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease.
Kohichi Kawahara; Makoto Hashimoto; Pazit Bar-On; Gilbert J Ho; Leslie Crews; Hideya Mizuno; Edward Rockenstein; Syed Z Imam; Eliezer Masliah
alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease.
Igor Tsigelny; Pazit Bar-On; Yuriy Sharikov; Leslie Crews; Makoto Hashimoto; Mark A Miller; Steven H Keller; Oleksandr Platoshyn; Jason X-J Yuan; Eliezer Masliah
Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pazit Bar-On (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Pazit Bar-On; Leslie Crews; Andrew O Koob; Hideya Mizuno; Anthony Adame; Brian Spencer; Eliezer Masliah
Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease.
Journal of neurochemistry 2008;105(5):1656-67.
2008: Kohichi Kawahara; Makoto Hashimoto; Pazit Bar-On; Gilbert J Ho; Leslie Crews; Hideya Mizuno; Edward Rockenstein; Syed Z Imam; Eliezer Masliah
alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease.
The Journal of biological chemistry 2008;283(11):6979-87.
2007: Igor Tsigelny; Pazit Bar-On; Yuriy Sharikov; Leslie Crews; Makoto Hashimoto; Mark A Miller; Steven H Keller; Oleksandr Platoshyn; Jason X-J Yuan; Eliezer Masliah
Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein.
The FEBS journal 2007;274(7):1862-77.
2007: Edward Rockenstein; Magdalena Torrance; Anthony Adame; Michael Mante; Pazit Bar-On; John B Rose; Leslie Crews; Eliezer Masliah
Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(8):1981-91.
2006: Pazit Bar-On; Edward Rockenstein; Anthony Adame; Gilbert Ho; Makoto Hashimoto; Eliezer Masliah
Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy.
Journal of neurochemistry 2006;98(4):1032-45.
2004: Makoto Hashimoto; Edward Rockenstein; Michael Mante; Leslie Crews; Pazit Bar-On; Fred H Gage; Robert Marr; Eliezer Masliah
An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model.
Gene therapy 2004;11(23):1713-23.
2004: Makoto Hashimoto; Pazit Bar-On; Gilbert Ho; Takato Takenouchi; Edward Rockenstein; Leslie Crews; Eliezer Masliah
Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease.
The Journal of biological chemistry 2004;279(22):23622-9.
2004: Makoto Hashimoto; Kohichi Kawahara; Pazit Bar-On; Edward Rockenstein; Leslie Crews; Eliezer Masliah
The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.
Journal of molecular neuroscience : MN 2004;24(3):343-52.